Expression of multidrug resistance-related transporters in human breast carcinoma

Japanese Journal of Cancer Research

Volumn 92, Issue 4, 2001, Pages 452-458

  Kanzaki, Atsuko ^a   Toi, Masakazu ^b   Nakayama, Kentaro ^a   Bando, Hiroko ^b   Mutoh, Masato ^c   Uchida, Takafumi ^a   Fukumoto, Manabu ^a   Takebayashi, Yuji ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c TORAY INDUSTRIES INC   (Japan)

Author keywords

BCRP; Breast carcinoma; MDR

Indexed keywords

DOXORUBICIN; ESTROGEN RECEPTOR; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER RESISTANCE; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0035012619     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01115.x     Document Type: Article

References (34)

1. Biochemistry of multidrug resistance mediated by the multidrug transporter
2. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
3. Multidrug resistance-associated protein: Sequence correction
4. The drug resistance-related protein LRP is the human major vault protein
5. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine
6. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells
7. Expression of a multidrug resistance gene in human cancers
8. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer
9. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells
10. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
11. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
12. A multidrug resistance transporter from human MCF-7 breast cancer cells
13. The mouse Bcrp1/Mxr/Abcp gene: Amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin
14. Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux
15. Camptothecin resistance: Role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells
16. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
17. Drug resistance in clinical oncology and hematology
18. MDR1 gene expression and prognostic factors in primary breast carcinomas
19. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines
20. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas
21. No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer
22. MDR1 gene expression in primary and advanced breast cancer
23. Expression of the lung resistance protein (LRP) in primary breast cancer
24. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: Correlation to messenger RNA expression and to immunohistochemical prognostic indicators
25. MRP and MDR1 gene expression in primary breast carcinomas
26. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer
27. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen
28. Using the national cancer institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profiles
29. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin
30. Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy
31. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer
32. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations
33. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors
34. Expression of drug resistance proteins in breast cancer, in relation to chemotherapy